177 related articles for article (PubMed ID: 12360477)
1. Antibody-mediated gastrointestinal dysmotility in scleroderma.
Goldblatt F; Gordon TP; Waterman SA
Gastroenterology; 2002 Oct; 123(4):1144-50. PubMed ID: 12360477
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility.
Park K; Park S; Jackson MW
Mol Immunol; 2013 Dec; 56(4):583-7. PubMed ID: 23911416
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
4. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
Cavill D; Waterman SA; Gordon TP
Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
[TBL] [Abstract][Full Text] [Related]
5. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
Park K; Haberberger RV; Gordon TP; Jackson MW
Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
[TBL] [Abstract][Full Text] [Related]
6. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
Cavill D; Waterman SA; Gordon TP
Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
[TBL] [Abstract][Full Text] [Related]
7. Role of anti-calcium channel and anti-receptor autoantibodies in autonomic dysfunction in Sjögren's syndrome.
Ohlsson M; Gordon TP; Waterman SA
J Neuroimmunol; 2002 Jun; 127(1-2):127-33. PubMed ID: 12044983
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility.
Kawaguchi Y; Nakamura Y; Matsumoto I; Nishimagi E; Satoh T; Kuwana M; Sumida T; Hara M
Ann Rheum Dis; 2009 May; 68(5):710-4. PubMed ID: 18762475
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells.
Singh J; Mehendiratta V; Del Galdo F; Jimenez SA; Cohen S; DiMarino AJ; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1206-13. PubMed ID: 19779020
[TBL] [Abstract][Full Text] [Related]
10. M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice.
Unno T; Matsuyama H; Sakamoto T; Uchiyama M; Izumi Y; Okamoto H; Yamada M; Wess J; Komori S
Br J Pharmacol; 2005 Sep; 146(1):98-108. PubMed ID: 15965495
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin receptor expression and function in human esophageal smooth muscle.
Kovac JR; Chrones T; Preiksaitis HG; Sims SM
J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of muscarinic M2 and M3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice.
Kitazawa T; Hashiba K; Cao J; Unno T; Komori S; Yamada M; Wess J; Taneike T
Eur J Pharmacol; 2007 Jan; 554(2-3):212-22. PubMed ID: 17113073
[TBL] [Abstract][Full Text] [Related]
13. Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable.
Matsui M; Motomura D; Fujikawa T; Jiang J; Takahashi S; Manabe T; Taketo MM
J Neurosci; 2002 Dec; 22(24):10627-32. PubMed ID: 12486155
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
[TBL] [Abstract][Full Text] [Related]
15. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
[TBL] [Abstract][Full Text] [Related]
16. Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG.
Kumar S; Singh J; Kedika R; Mendoza F; Jimenez SA; Blomain ES; DiMarino AJ; Cohen S; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1052-60. PubMed ID: 27173508
[TBL] [Abstract][Full Text] [Related]
17. Deletion of TRPC4 and TRPC6 in mice impairs smooth muscle contraction and intestinal motility in vivo.
Tsvilovskyy VV; Zholos AV; Aberle T; Philipp SE; Dietrich A; Zhu MX; Birnbaumer L; Freichel M; Flockerzi V
Gastroenterology; 2009 Oct; 137(4):1415-24. PubMed ID: 19549525
[TBL] [Abstract][Full Text] [Related]
18. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.
Bacman SR; Berra A; Sterin-Borda L; Borda ES
Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535
[TBL] [Abstract][Full Text] [Related]
19. Enhanced nerve-stimulated muscarinic and neurokinin contractions of ileum from streptozotocin guinea-pigs.
Cellini J; Pommier R; Porter R; LePard KJ
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):23-39. PubMed ID: 22676206
[TBL] [Abstract][Full Text] [Related]
20. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle.
Ehlert FJ; Sawyer GW; Esqueda EE
Life Sci; 1999; 64(6-7):387-94. PubMed ID: 10069501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
